Antibiotic-Driven Gut Microbiome Dysbiosis: Resistome Dynamics, Metabolic Disruption, and Paths to Restoration
Antibiotics · 15.07.2026 · 15 (7) · 688
DOI: 10.3390/antibiotics15070688 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 15.07.2026. Verfasst von Adelina-Gabriela Niculescu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of the University of Bucharest-ICUB, University of Bucharest, 050657 Bucharest, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Executive Unit for Financing Higher Education, Research, Development and Innovation, Ministry of Research and Innovation, Ministry of Research, Innovation and Digitization.
Abstract (Originalsprache)
The gut microbiome is a dynamic ecosystem that plays essential roles in host metabolism, immune regulation, colonization resistance, and maintenance of intestinal homeostasis. Antibiotic exposure profoundly disrupts this ecosystem by reducing microbial diversity, depleting beneficial commensals, reshaping microbial metabolic functions, and remodeling the gut resistome through the selection and dissemination of antibiotic resistance genes (ARGs). Increasing evidence from longitudinal metagenomic, multi-omics, and experimental studies indicates that these perturbations may persist long after antibiotic withdrawal due to incomplete ecological recovery, sustained mobile genetic element-mediated ARG dissemination, and altered microbiome resilience. Beyond antimicrobial resistance, antibiotic-induced dysbiosis has been associated with reduced short-chain fatty acid production, altered bile acid metabolism, impaired epithelial barrier function, and broader disturbances in host metabolic homeostasis, although many of these relationships remain associative rather than causal. This review provides an integrated overview of antibiotic-driven gut microbiome dysbiosis, emphasizing the ecological, functional, metabolic, and resistome-level consequences of antibiotic exposure together with the mechanisms governing microbiome recovery. Current microbiome-targeted restoration strategies, including probiotics, phage therapy, fecal microbiota transplantation, and next-generation microbiome therapeutics, are critically evaluated with particular attention to their evidence maturity, limitations, and translational potential. Finally, key knowledge gaps and future research priorities are discussed to support the development of more effective microbiome-preserving antimicrobial strategies and to limit the long-term dissemination of antimicrobial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute of the University of Bucharest-ICUB, University of Bucharest, 050657 Bucharest, Romania.
- Department of Science and Engineering of Oxide Materials and Nanomaterials, National University of Science and Technology Politehnica Bucharest, 011061 Bucharest, Romania.
- Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- "Prof. Dr. Panait Sîrbu" Obstetrics and Gynecology Hospital, 060251 Bucharest, Romania.
- Obstetrics and Gynecology Department, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Bacteriology Branch, Veterinary Sciences Division, Agri-Food and Biosciences Institute, Belfast BT4 3SD, UK.
ORCID-Profile: Adelina-Gabriela Niculescu, Elvira Brătilă, Raluca Tocariu, Ciprian Andrei Coroleucă, Nicolae Corcionivoschi, Corneliu Ovidiu Vrancianu, Gabriela Loredana Popa, Mircea Ioan Popa, Georgiana-Alexandra Grigore
Förderung
- Executive Unit for Financing Higher Education, Research, Development and Innovation
- Ministry of Research and Innovation
- Ministry of Research, Innovation and Digitization
Zitieren
APA
Niculescu, A. G., Iacob, C. M., Brătilă, E., Tocariu, R., Coroleucă, C. A., Corcionivoschi, N., Vrancianu, C. O., Popescu, D. L., Popa, G. L., Popa, M. I., Cristian, R. E., & Grigore, G. A. (2026). Antibiotic-Driven Gut Microbiome Dysbiosis: Resistome Dynamics, Metabolic Disruption, and Paths to Restoration. Antibiotics, 15(7), 688. https://doi.org/10.3390/antibiotics15070688
Vancouver
Niculescu AG, Iacob CM, Brătilă E, Tocariu R, Coroleucă CA, Corcionivoschi N, et al. Antibiotic-Driven Gut Microbiome Dysbiosis: Resistome Dynamics, Metabolic Disruption, and Paths to Restoration. Antibiotics. 2026;15(7):688. doi:10.3390/antibiotics15070688
BibTeX
@article{Niculescu2026,
author = {Niculescu, Adelina-Gabriela and Iacob, Cristina-Maria and Brătilă, Elvira and Tocariu, Raluca and Coroleucă, Ciprian Andrei and Corcionivoschi, Nicolae and Vrancianu, Corneliu Ovidiu and Popescu, Delia-Laura and Popa, Gabriela Loredana and Popa, Mircea Ioan and Cristian, Roxana-Elena and Grigore, Georgiana-Alexandra},
title = {Antibiotic-Driven Gut Microbiome Dysbiosis: Resistome Dynamics, Metabolic Disruption, and Paths to Restoration},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {7},
pages = {688},
doi = {10.3390/antibiotics15070688}
}
EUVIMED